China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the industry—and Washington—are rethinking the risks.

VIR-5500 ASCO GU update, VIR-5818 H2’26, ECLIPSE 1 Q4’26 + more hepatitis delta readouts. See more details here.

Biotechnology is the exploitation of biological processes for the development of technologies and products for a specific use. GlobalData’s Strategic Intelligence report on biotech details how recent ...

Over in Grant, the Tennessee Valley Authority awarded funding to a science class at Kate Duncan Smith DAR Middle School to ...

The Invesco Biotechnology & Genome ETF (PBE) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. What ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

The Invesco Biotechnology & Genome ETF (PBE) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Explore evolving career pathways in biotechnology, emphasizing innovation, sustainability, and interdisciplinary skills from ...

Moyom Biotechnology recently announced a strategic partnership with WPP Group, one of the world's leading global ...

The 11th International Plant Tissue Culture and Biotechnology Conference concluded on Monday at the Department of Botany, ...

Admissions open for Ph.D. in Agricultural, Food, and Biomanufacturing fields at NABI, with degree awarded by RCB.